A detailed history of Great Valley Advisor Group, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 40,455 shares of BSX stock, worth $3.65 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
40,455
Previous 39,381 2.73%
Holding current value
$3.65 Million
Previous $3.03 Million 11.81%
% of portfolio
0.09%
Previous 0.09%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$72.96 - $84.0 $78,359 - $90,216
1,074 Added 2.73%
40,455 $3.39 Million
Q2 2024

Jul 16, 2024

BUY
$67.33 - $77.71 $240,839 - $277,968
3,577 Added 9.99%
39,381 $3.03 Million
Q1 2024

May 03, 2024

SELL
$57.6 - $68.62 $7,488 - $8,920
-130 Reduced 0.36%
35,804 $2.45 Million
Q4 2023

Feb 05, 2024

BUY
$48.64 - $57.81 $479,541 - $569,948
9,859 Added 37.81%
35,934 $2.08 Million
Q3 2023

Nov 06, 2023

BUY
$50.19 - $54.68 $68,810 - $74,966
1,371 Added 5.55%
26,075 $1.38 Million
Q2 2023

Aug 10, 2023

BUY
$49.72 - $54.64 $156,966 - $172,498
3,157 Added 14.65%
24,704 $1.34 Million
Q1 2023

May 02, 2023

BUY
$45.09 - $50.03 $386,872 - $429,257
8,580 Added 66.17%
21,547 $1.08 Million
Q4 2022

Jan 31, 2023

SELL
$39.56 - $47.22 $5,894 - $7,035
-149 Reduced 1.14%
12,967 $600,000
Q3 2022

Oct 21, 2022

BUY
$36.71 - $109.66 $17,400 - $51,978
474 Added 3.75%
13,116 $508,000
Q2 2022

Jul 19, 2022

BUY
$35.24 - $47.1 $157,064 - $209,924
4,457 Added 54.45%
12,642 $471,000
Q1 2022

Apr 20, 2022

BUY
$40.9 - $45.1 $118,446 - $130,609
2,896 Added 54.76%
8,185 $362,000
Q4 2021

Feb 10, 2022

BUY
$38.07 - $44.87 $13,629 - $16,063
358 Added 7.26%
5,289 $225,000
Q3 2021

Oct 14, 2021

BUY
$41.23 - $45.88 $203,305 - $226,234
4,931 New
4,931 $214,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Great Valley Advisor Group, Inc. Portfolio

Follow Great Valley Advisor Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Valley Advisor Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Great Valley Advisor Group, Inc. with notifications on news.